England’s NHS Will No Longer Provide Puberty Blockers to Transgender Kids

England has ceased providing puberty blockers to gender identity clinics due to concerns about potential harm to children.

The National Health Service (NHS) cited insufficient evidence to support the safety or effectiveness of these hormones. Puberty blockers will only be available to transgender youths participating in clinical research.

Critics argue these drugs pose significant risks, including potential brain maturation delays and lack of long-term safety data. Former Prime Minister Liz Truss seeks to extend the ban to private practices, emphasizing the importance of evidence-based care for children.

Health Minister Maria Caulfield supports the decision, aiming to prioritize children’s well-being. International studies and health institutions echo concerns over the risks of puberty blockers and cross-sex hormones.